A Clinical Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Heparin in Patients Who Are on Haemodialysis
PHASE2CompletedINTERVENTIONAL
Enrollment
260
Participants
Timeline
Start Date
November 30, 2003
Study Completion Date
January 31, 2006
Conditions
Chronic Kidney FailureVascular Graft Occlusion
Interventions
DRUG
PEG-hirudin
Trial Locations (1)
19106
Pennsylvania Hospital - Franklin Dialysis Center, Philadelphia
All Listed Sponsors
collaborator
Quintiles, Inc.
INDUSTRY
lead
Speedel Pharma Ltd.
INDUSTRY
NCT00074620 - A Clinical Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Heparin in Patients Who Are on Haemodialysis | Biotech Hunter | Biotech Hunter